Design Therapeutics Inc (DSGN)

Stockholders Equity

$201.86M

Quarterly · Period ending: · USD

DSGN logo

DSGN Stockholders Equity

Latest reported$201.86M
DSGN Quarterly Shareholders Equity (-$3.64M → $201.86M)
High-resolution chart · PNG

DSGN stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Design Therapeutics Inc Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
201,858,000
218,054,000
212,503,000
199,720,000
213,037,000
227,919,000
242,097,000
252,453,000
261,242,000
269,557,000
277,687,000
284,957,000
296,795,000
312,818,000
327,310,000
340,938,000
357,163,000
370,309,000
382,130,000
391,564,000
401,601,000
408,006,000
-11,315,000
-3,642,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.